Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction-Reference-Cited by-同舟云学术

Fas/Fas Ligand Mediates Keratinocyte Death in Sunitinib-Induced Hand-Foot Skin Reaction

Published:2014-11 Issue:11 Volume:134 Page:2768-2775
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Yeh Chun-Nan,Chung Wen-Hung,Su Shih-Chi,Chen Yen-Yang,Cheng Chi-Tung,Lin Yen-Ling,Chang Wan-Chun,Chung-Yee Hui Rosaline,Chiang Kun-Chun,Chen Tsung-Wen,Jan Yi-Yin,Chen Chien-Wei,Chen Ting-Jui,Yang Chih-Hsun,Hung Shuen-Iu

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference38 articles.

1. Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors;Adams;Clin Ther,2007

2. Fas transduces activation signals in normal human T lymphocytes;Alderson;J Exp Med,1993

3. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs);Anderson;Oncologist,2009

4. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice;Baker;J Exp Med,1996

5. Fas (CD95) and bcl-2 expression in active skin lesions of Behcet’s disease;Baris;J Eur Acad Dermatol Venereol,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Keratinocyte Cytoprotectants against Toxicity by the Multikinase Inhibitor Sorafenib Using Drug Repositioning;JID Innovations;2024-05

2. A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction;Biological Trace Element Research;2023-03-09

3. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14

4. Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes;Oral Diseases;2023-01-04

5. Dermatologic Complications of Cancer Chemotherapy;Holland‐Frei Cancer Medicine;2022-10-21